-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Jill DeSimone - @desij10
Mckaylee Desimone - @MckayleeDe95419
Stacking sats and embracing the future of digital currency. #StackingSats #DigitalCurrency
Sponsored by SpokeoPaid Service
Jill M Desimone
L*****@gmail.com — (609) 683-****
***** Preservation Dr, Sarasota, FL
View full reportSponsored by PeopleLookerPaid Service
(734) 368-****
Jill Desimone, Westland, MI
Sponsored by SpokeoPaid Service
Jill Desimone
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
jilldesimone - @jilldesimone
5 followers
Jillsimone 😊❤️😊 - @jillsimone
96 followers
Juli Desimone - @julidesimone
2,595 followers
Juli - @julii_desimone
363 followers
jilldesmond - @jilldesmond
3 followers
Jill DeSimone
Senior Manager - Hilton
Mannino Michael
Cardiologist - Manhasset Medical Associates
Joshua Klein
Cardiologist - Cohen, Bergman & Klepper MDs
Education: Albert Einstein College of Medicine of Yeshiva ...
John Burns
Cardiologist - Cardiology Associates of New Brunswick
Anne Deitz
Merck
Sarah Misenko
Merck
Danielle Keller
Prathima Patel
Senior Director, Solid Tumor Oncology Global ...
Jill (Thibault) Desimone
-
White Pines High School (1982 - 1986)
Sault Ste. Marie, ON
Jill Desimone
-
Swampscott High School (1969 - 1973)
Swampscott, MA
Jill Desimone
Sponsored by PeopleLookerPaid Service
Search for Jill Desimone's city and state history
Search address historyHall of Femme Archives
Medical Marketing and Media - Thu, 18 Jan 2018
iTeos Therapeutics expands board with industry veteran
Investing.com - Wed, 06 Mar 2024
Football Hall of Famer and Cancer Survivor Jim Kelly Joins Merck to Challenge America to Raise Funds for the Cancer Community
drugdiscoverytrends.com - Wed, 31 Jan 2018
Teva promotes Allan Oberman to take over from William Marth
PMLiVE - Thu, 08 Nov 2012
Merck drafts game plan for lung cancer with awareness campaign expansion
Fierce Pharma - Wed, 29 Nov 2017
Starring in That Drug Commercial? An Actual Patient (Published 2018)
The New York Times - Sun, 23 Sep 2018
Daniel R. Moisan and Maria E. Lalli
Newport Daily News - Sat, 13 Dec 2014
Jill DeSimone - @jillerica
104 followers
Jill DeSimone - @jestravel
58 followers
Jill Desimone - @jilldesimone10
17 followers
Jill DeSimone - @desij10
4 followers
Jill DeSimone - @soccagal109
2 followers
Jill DeSimone - @jilldesimone
1 follower
Jill Desimone - @jilldesimone12
7 followers
Jill DeSimone - @desimonejillian
0 followers
Jill Desimone - @dessamjill
0 followers
Jill Desimone - @jillmdesimone
1 follower
![U.S. 1 [9/17/03] - Archives](https://archive.org/services/img/us19170300unse "U.S. 1 [9/17/03] - Archives")
Jill DeSimone | Affini-T Therapeutics
Jill DeSimone brings more than 40 years of global business expertise in life sciences to Affini-T’s board. Most recently, she served as President of U.S.
Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors
BOSTON & SEATTLE-- ( BUSINESS WIRE )-- Affini-T Therapeutics, Inc ., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, …
Florida Cancer Specialists Foundation (FCSF) Welcomes New …
The Florida Cancer Specialists (FCS) Foundation (FCSF) is adding pharmaceutical executive Jill DeSimone to its Board of Directors, as well as announcing the …
Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors
Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors. 07.11.2022. BOSTON, Mass., and SEATTLE, Wash. – July 12, 2022 – Affini-T Therapeutics, …
Jill DeSimone | Oncternal Therapeutics
Jill DeSimone. Ms. DeSimone was most recently President of U.S. Oncology at Merck & Co., Inc., where she built the company’s oncology division, growing it to over a $9 billion …
Jill Desimone | iTeos
With over 40 years of global business expertise in life sciences, Ms. DeSimone is recognized for her role as President of U.S. Oncology at Merck & Co., Inc., where she established the company’s oncology division, …
Oncternal Therapeutics Announces the Appointment of Jill …
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel …
Jill DeSimone - Director at Kinnate Biopharma | The Org
Jill DeSimone brings more than 40 years of global business expertise in life sciences to Kinnate’s board. Most recently, she served as President of U.S.
Indegene Hosts Inaugural Strategic Advisory Board Meeting …
Princeton, N.J., April 02, 2024: Indegene, a digital-first, life sciences commercialization company, hosted its first Strategic Advisory Board (SAB) meeting recently in New Jersey, …
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of …
With over 40 years of global business expertise in life sciences, Ms. DeSimone is recognized for her role as President of U.S. Oncology at Merck & Co., Inc., where she …
Global Healthcare Executive Jill DeSimone Joins Swim Across …
Global Healthcare Executive Jill DeSimone Joins Swim Across America Board of Directors. After a Successful Career with Oncology Pharmaceutical Companies, DeSimone …
iTeos Therapeutics | iTeos Appoints Oncology Veteran Jill …
After the recent appointment of Servier’s David Lee, we are thrilled to welcome Jill DeSimone to our Board of Directors during an important time in iTeos’ evolution.
Jill DeSimone: Positions, Relations and Network | MarketScreener
Director/Board Member at Praxis Precision Medicines, Inc., Discover Jill DeSimone's known position history, network and 99 relationships. Find out about his known …
Jill DeSimone, Merck - MM+M | Medical Marketing and Media
He believed in me, giving me my first shot to own a P&L, which was uncommon among women at the time. My current boss, Frank Clyburn (human health president of …
Jill DeSimone | Board Member | iTeos Therapeutics
Our innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for …
Jill DeSimone joins Swim Across America’s board of directors
Jill DeSimone, a global pharmaceutical executive, joined Swim Across America’s board of directors.
Oncternal Therapeutics Announces the Appointment of Jill …
Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, …